Quantum Genesis AI Corp. (OTC: QGAI) announced today that the Caveat Emptor designation previously applied to its securities by OTC Markets Group has been removed, marking a significant milestone for the company's public market standing. The Caveat Emptor designation, which alerts investors to potential issues with a company's public disclosures or regulatory compliance, had been a barrier to investor confidence and trading liquidity.
The company expressed appreciation for the opportunity to engage with OTC Markets throughout the review process and acknowledged the professionalism and assistance provided. Quantum Genesis AI worked cooperatively to provide information and respond to inquiries during the review period. Naveen Kulkarni, Chief Executive Officer, stated, 'We appreciate the time and attention that OTC Markets dedicated to this matter and are pleased that the review process has concluded with the removal of the Caveat Emptor designation. Throughout this process, our focus remained on transparency, responsiveness, and constructive engagement.'
The removal of the designation is expected to restore normal trading conditions and enhance investor perception. It reflects the company's commitment to responsible corporate governance and public company compliance. Quantum Genesis AI continues to advance its strategic initiatives in artificial intelligence, computational modeling, and scientific innovation. The company intends to provide timely updates regarding its business activities and corporate developments through public disclosures and shareholder communications.
For more information, visit www.qgaicorp.com and the company's profile at www.otcmarkets.com/stock/QGAI.
